What are the new drugs for rheumatoid arthritis (RA)?
Official Answer by Drugs.com
The newest drugs for the treatment of rheumatoid arthritis are the Janus kinase (JAK) inhibitors, which are FDA approved under the brand names Rinvoq, Olumiant, and Xeljanz.
Janus kinase (JAK) inhibitors work by blocking the activity of one or more of the Janus kinase enzymes (JAK1, JAK2, JAK3, TYK2) in the JAK-STAT signaling pathway, an intracellular pathway that plays a major role in the release of the pro-inflammatory cytokines that stimulate inflammation in rheumatoid arthritis.
Janus kinase (JAK) inhibitors are part of a wider group of drugs called DMARDs (Disease-Modifying Anti-Rheumatic Drugs). DMARDs work to slow the progression of joint damage in rheumatoid arthritis.
For more information on the treatment of rheumatoid arthritis, see Rheumatoid Arthritis: Symptoms, Diagnosis & Treatment Options
New Treatments for Rheumatoid Arthritis - Latest FDA Approvals
| Drug | Drug Class | Administration | Company | FDA Approved for RA | RA Indication | Other Indications |
|---|---|---|---|---|---|---|
| upadacitinib (Rinvoq) | Janus kinase (JAK) inhibitor |
oral extended-release tablets once daily |
AbbVie Inc. | 16-Aug-2019 |
|
|
| baricitinib (Olumiant) | Janus kinase (JAK) inhibitor | oral tablets once daily | Eli Lilly and Company | 31-May-2018 |
|
|
| sarilumab (Kevzara) | interleukin-6 (IL-6) receptor antagonist |
subcutaneous injection every 2 weeks |
Sanofi and Regeneron | 22-May-2017 |
|
|
| tofacitinib (Xeljanz XR) | Janus kinase (JAK) inhibitor | oral extended-release tablets once daily | Pfizer Inc. | 23-Feb-2016 |
|
|
| golimumab (Simponi Aria) | tumor necrosis factor (TNF) blocker | intravenous infusion at weeks 0 and 4, then every 8 weeks | Janssen Biotech, Inc. | 18-Jul-2013 |
|
|
| tofacitinib (Xeljanz) | Janus kinase (JAK) inhibitor | oral tablets twice daily | Pfizer Inc. | 6-Nov-2012 |
|
|
| tocilizumab (Actemra) | interleukin-6 (IL-6) receptor antagonist |
intravenous infusion every 4 weeks subcutaneous injection every 2 weeks, then every week |
Genentech, Inc. | 8-Jan-2010 |
|
|
| certolizumab pegol (Cimzia) | tumor necrosis factor (TNF) blocker | subcutaneous injection at weeks 0, 2, and 4, then every 2-4 weeks | UCB, Inc. | 13-May-2009 |
|
|
| golimumab (Simponi) | tumor necrosis factor (TNF) blocker |
subcutaneous injection once a month |
Janssen Biotech, Inc. | 24-Apr-2009 |
|
|
| rituximab (Rituxan) | CD20-directed cytolytic antibody | intravenous infusion two infusions separated by 2 weeks (one course) every 24 weeks or based on clinical evaluation (not sooner than every 16 weeks) | Genentech, Inc. | 28-Feb-2006 |
|
|
| abatacept (Orencia) | selective T cell costimulation modulator |
intravenous infusion at 0, 2 and 4 weeks, then every 4 weeks subcutaneous injection once weekly |
Bristol-Myers Squibb Company | 23-Dec-2005 |
|
|
| adalimumab (Humira) | tumor necrosis factor (TNF) blocker |
subcutaneous injection every 2 weeks |
AbbVie Inc. | 31-Dec-2002 |
|
|
| anakinra (Kineret) | interleukin-1 receptor antagonist |
subcutaneous injection once daily |
Swedish Orphan Biovitrum AB | 14-Nov-2001 |
|
|
| infliximab (Remicade) | tumor necrosis factor (TNF) blocker | intravenous infusion at 0, 2, and 6 weeks, then every 8 weeks | Janssen Biotech, Inc. | 10-Nov-1999 |
|
|
| etanercept (Enbrel) | tumor necrosis factor (TNF) blocker |
subcutaneous injection once weekly |
Immunex Corporation | 2-Nov-1998 |
|
|
| leflunomide (Arava) | pyrimidine synthesis inhibitor | oral tablets once daily | sanofi-aventis U.S. LLC | 10-Sep-1998 |
|
|
The biosimilars for Actemra, Rituxan, Humira, Remicade, and Enbrel are also FDA approved for the treatment of rheumatoid arthritis:
Related questions
- What medications are known to cause hair loss?
- Can you take Humira with antibiotics?
- Cosentyx vs Humira: How do they compare?
Actemra (tocilizumab) Biosimilars
Rituxan (rituximab) Biosimilars
Humira (adalimumab) Biosimilars
- Amjevita (adalimumab-atto)
- Cyltezo (adalimumab-adbm)
- Hyrimoz (adalimumab-adaz)
- Hadlima (adalimumab-bwwd)
- Abrilada (adalimumab-afzb)
- Hulio (adalimumab-fkjp)
- Yusimry (adalimumab-aqvh)
- Idacio (adalimumab-aacf)
- Yuflyma (adalimumab-aaty)
- Simlandi (adalimumab-ryvk)
Remicade (infliximab) Biosimilars
- Inflectra (infliximab-dyyb)
- Renflexis (infliximab-abda)
- Ixifi (infliximab-qbtx)
- Avsola (infliximab-axxq)
Enbrel (etanercept) Biosimilars
Read next
Skyrizi vs Humira for plaque psoriasis - How do they compare?
In a head-to-head clinical study between Skyrizi and Humira, researchers found that Skyrizi was better than Humira at clearing moderate-to-severe plaque psoriasis in adults. At 16 weeks, 72% of patients given Skyrizi achieved 90% clearer skin compared to 47% of patients given Humira, a statistically significant outcome. Continue reading
Is Amjevita interchangeable with Humira?
Amjevita is not yet interchangeable with Humira, and the pharmacist must get approval from your doctor before they can substitute it for Humira. The approved interchangeable biosimilars for Humira are Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, and Simlandi according to the FDA Purple Book as of March 2025. Continue reading
What is the difference between Cyltezo and Humira?
Cyltezo (adalimumab-adbm) is an FDA-approved interchangeable biosimilar to Humira (adalimumab). Both medications are used to treat similar conditions, with slight differences in age group approvals. Continue reading
See also:
Related medical questions
- What are the new drugs for plaque psoriasis?
- What are biologic drugs and how do they work?
- What biosimilars have been approved in the United States?
- What is the difference between Amjevita and Humira?
- New 'Biosimilars' may help Reduce Medication Costs
- How soon can you start chemo after port placement?
- What is the difference between Truxima and Rituxan?
- What is the success rate of Rituxan (rituximab) in patients with blood cancers?
- What is a chemotherapy regimen?
- What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?
- What causes infusion reactions to rituximab?
- What is the difference between Rituxan and Rituxan Hycela?
- Are lung nodules common after Bendeka & Rituxan therapy?
- What is the mechanism of action of infliximab?
- What is the difference between Inflectra and Remicade?
- What is the difference between Renflexis and Remicade?
- What is the difference between Ixifi and Remicade?
- What are JAK inhibitors and how do they work?
- Which JAK inhibitors are approved in the U.S?
- Litfulo vs Olumiant: How do they compare?
- How effective is Olumiant for Alopecia Areata (hair loss)?
- Is baricitinib (Olumiant) being used to treat COVID-19?
- What type of drug is Olumiant (baricitinib)?
Related support groups
- Adalimumab (15 questions, 14 members)
- Rituximab (13 questions, 56 members)
- Infliximab (9 questions, 15 members)
- Olumiant (7 questions, 4 members)
- Renflexis (6 questions, 4 members)
- Baricitinib (4 questions, 4 members)
- Humira (69 questions, 370 members)
- Enbrel (25 questions, 212 members)
- Remicade (23 questions, 186 members)
- Xeljanz (21 questions, 38 members)
- Rituxan (21 questions, 105 members)